CN Patent

CN115920065A — 一种可靶向去唾液酸糖蛋白受体的配体及其缀合物与用途

Assigned to Southern University of Science and Technology · Expires 2023-04-07 · 3y expired

What this patent protects

一种可靶向去唾液酸糖蛋白受体的配体及其用途，本发明的配体可以特异性地靶向结合至肝细胞表面的去唾液酸糖蛋白受体(ASGPR)，可用于相关疾病的靶向治疗，具有广阔的市场应用前景。

USPTO Abstract

一种可靶向去唾液酸糖蛋白受体的配体及其用途，本发明的配体可以特异性地靶向结合至肝细胞表面的去唾液酸糖蛋白受体(ASGPR)，可用于相关疾病的靶向治疗，具有广阔的市场应用前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN115920065A
Jurisdiction
CN
Classification
—
Expires
2023-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Southern University of Science and Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.